DF
GILD icon

Donoghue Forlines’s Gilead Sciences GILD Stock Holding History

Donoghue Forlines’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.22M Buy
+23,126
New +$3.24M 0.89% 22
2025
Q2 		– Sell
-19,758
Closed -$2.21M – 114
2025
Q1 		$2.21M Sell
19,758
-20,196
-51% -$2.08M 0.7% 48
2024
Q4 		$3.69M Buy
39,954
+13,524
+51% +$1.22M 1.23% 6
2024
Q3 		$2.22M Buy
26,430
+6,357
+32% +$485K 0.63% 31
2024
Q2 		$1.38M Buy
20,073
+2,309
+13% +$154K 0.39% 71
2024
Q1 		$1.3M Buy
17,764
+3,229
+22% +$248K 0.37% 81
2023
Q4 		$1.18M Sell
14,535
-19,949
-58% -$1.55M 0.37% 80
2023
Q3 		$2.58M Buy
34,484
+6,151
+22% +$473K 0.92% 16
2023
Q2 		$2.18M Buy
28,333
+2,227
+9% +$178K 0.68% 23
2023
Q1 		$2.17M Sell
26,106
-5,455
-17% -$452K 0.78% 16
2022
Q4 		$2.71M Buy
31,561
+17,022
+117% +$1.35M 0.96% 16
2022
Q3 		$897K Sell
14,539
-12,808
-47% -$808K 0.32% 43
2022
Q2 		$1.69M Sell
27,347
-14,415
-35% -$892K 0.44% 32
2022
Q1 		$2.48M Buy
41,762
+9,573
+30% +$612K 0.54% 31
2021
Q4 		$2.34M Sell
32,189
-2,245
-7% -$155K 0.4% 45
2021
Q3 		$2.4M Buy
34,434
+14,845
+76% +$1.04M 0.47% 46
2021
Q2 		$1.35M Buy
19,589
+268
+1% +$17.9K 0.25% 92
2021
Q1 		$1.25M Sell
19,321
-18,853
-49% -$1.22M 0.24% 106
2020
Q4 		$2.22M Buy
+38,174
New +$2.3M 0.43% 36
2019
Q4 		– Sell
-65,953
Closed -$4.18M – 171
2019
Q3 		$4.18M Sell
65,953
-30,722
-32% -$2.01M 0.6% 59
2019
Q2 		$6.53M Buy
+96,675
New +$6.36M 0.76% 47
2018
Q4 		– Sell
-183,324
Closed -$14.2M – 78
2018
Q3 		$14.2M Sell
183,324
-42,799
-19% -$3.23M 1.1% 21
2018
Q2 		$16M Buy
226,123
+4,424
+2% +$312K 1.32% 32
2018
Q1 		$16.7M Sell
221,699
-15,000
-6% -$1.19M 1.45% 38
2017
Q4 		$17M Buy
236,699
+209,486
+770% +$15.9M 1.28% 51
2017
Q3 		$2.21M Buy
+27,213
New +$2.08M 0.23% 79

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Donoghue Forlines's GILD Position: Q1 2026 in Review

Donoghue Forlines opened a new position in Gilead Sciences (GILD) in Q1 2026: 23,126 shares worth $3.22M. The stake represents 0.89% of the portfolio and ranks #22 among its holdings. This is a return to the name: Donoghue Forlines previously reported a position in GILD as recently as Q1 2025.

Donoghue Forlines first reported a position in GILD in Q3 2017 and has held it in 26 quarters since. The position peaked at $17M in Q4 2017. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Donoghue Forlines held 23,126 shares of Gilead Sciences worth $3.22M as of Q1 2026.
  • Gilead Sciences was a new Donoghue Forlines position in Q1 2026.
  • Gilead Sciences made up 0.89% of Donoghue Forlines's portfolio in Q1 2026, its #22 holding.
  • Donoghue Forlines first reported a position in Gilead Sciences in Q3 2017 and has held it in 26 quarters since.
  • Donoghue Forlines's Gilead Sciences position peaked at $17M in Q4 2017.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Donoghue Forlines's 13F filing for Q1 2026, filed 13 May 2026.